SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Renovar Regulatory News (MRV)

Share Price Information for Maven Renovar (MRV)

Share Price is delayed by 15 minutes
Get Live Data
53.25    0.00 (0.00%)
Bid:
53.00
Ask:
53.50
Spread: 0.50 (0.943%)
Market Cap: £68.50m
MRV Live PriceLast checked at - London Stock Exchange

Intraday Maven Renovar Share Chart

Circular Distribution

18 Nov 2005 15:19

Murray VCT 2 PLC18 November 2005 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTOAUSTRALIA, CANADA, JAPAN, OR THE UNITED STATES OF AMERICA. THIS ANNOUNCEMENTDOES NOT CONSTITUTE OR FORM PART OF AN OFFER TO SELL, PURCHASE, EXCHANGE ORSUBSCRIBE FOR ANY SECURITIES OR SOLICITATION OF SUCH AN OFFER IN THE UNITEDSTATES OF AMERICA OR ANY OTHER JURISDICTION. THE SECURITIES REFERRED TO IN THISANNOUNCEMENT HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATESSECURITIES ACT OF 1933, AS AMENDED, AND WILL NOT BE OFFERED OR SOLD IN THEUNITED STATES EXCEPT PURSUANT TO AN APPLICABLE EXEMPTION FROM REGISTRATION 18 November 2005 RECOMMENDED MERGER BETWEEN MURRAY VCT 3 PLC, MURRAY VCT PLC AND MURRAY VCT 2 PLCAND RELATED PROPOSALS In connection with the announcement made on 17 November 2005 relating to therecommended merger between Murray VCT 3 PLC, Murray VCT PLC and Murray VCT 2 PLC(the "Companies") and related proposals, the boards of the Companies announcethat circulars relating to each company and a prospectus for Murray VCT 3 PLCare today being posted to shareholders. The necessary meetings to consider theproposals are being convened for 12 December 2005. Copies of the circulars and the prospectus have been submitted to the FSA andwill shortly be available for inspection at the UK Listing Authority's DocumentViewing Facility, which is situated at: Document Viewing FacilityUK Listing Authority25 The North ColonnadeCanary WharfLondon E14 5HSTel. 020 7066 1000 Enquiries Patrick Reeve 020 7422 7830Emil Gigov 020 7422 7830Close Venture Management Limited Todd Nugent 0131 226 7011Noble Grossart Limited, advisers to Murray VCT 3 plc Allan Treacy 01223 422 396AGM Corporate Finance LLP, advisers to Murray VCT plc Robert Lo 020 7710 7400Nabarro Wells & Co Limited, advisers to Murray VCT 2plc John West 020 7920 3150Clemmie CarrTavistock Communications Shareholder helpline 020 7621 1358HQB Consulting Limited The directors of Murray VCT 3 PLC accept responsibility for the informationrelating to Murray VCT 3 PLC and its directors in this document. To the best ofthe knowledge and belief of such directors (who have taken all reasonable careto ensure that such is the case), the information relating to Murray VCT 3 PLCand its directors contained in this document, for which they are solelyresponsible, is in accordance with the facts and does not omit anything likelyto affect the import of such information. The directors of Murray VCT PLC accept responsibility for the informationrelating to Murray VCT PLC and its directors in this document. To the best ofthe knowledge and belief of such directors (who have taken all reasonable careto ensure that such is the case), the information relating to Murray VCT PLC andits directors contained in this document, for which they are solely responsible,is in accordance with the facts and does not omit anything likely to affect theimport of such information. The directors of Murray VCT 2 PLC accept responsibility for the informationrelating to Murray VCT 2 PLC and its directors in this document. To the best ofthe knowledge and belief of such directors (who have taken all reasonable careto ensure that such is the case), the information relating to Murray VCT 2 PLCand its directors contained in this document, for which they are solelyresponsible, is in accordance with the facts and does not omit anything likelyto affect the import of such information. Noble Grossart Limited, AGM Corporate Finance LLP and Nabarro Wells & Co Limitedare acting exclusively for than Murray VCT 3 PLC, Murray VCT PLC and Murray VCT2 PLC, respectively, and for no one else in connection with the mattersdescribed herein and will not be responsible to anyone other than Murray VCT 3PLC, Murray VCT PLC and Murray VCT 2 PLC, respectively, for providing theprotections afforded to clients of Noble Grossart Limited, AGM Corporate FinanceLLP and Nabarro Wells & Co Limited nor for providing advice in relation to thematters described herein. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Jan 202610:00 amRNSTransaction in Own Shares
23rd Jan 20264:29 pmRNSUnaudited Net Asset Value
20th Jan 20264:28 pmRNSTransaction in Own Shares
19th Jan 202610:03 amRNSUnaudited Net Asset Value
14th Jan 20262:16 pmRNSTransaction in Own Shares
13th Jan 202612:11 pmRNSDirector Declaration
9th Jan 20263:51 pmRNSUnaudited Net Asset Value
6th Jan 20265:02 pmRNSTransaction in Own Shares
2nd Jan 20262:16 pmRNSUnaudited Net Asset Value
2nd Jan 202612:26 pmRNSTotal Voting Rights
29th Dec 202511:59 amRNSTransaction in Own Shares
29th Dec 202511:59 amRNSTransaction in Own Shares
19th Dec 20253:39 pmRNSUnaudited Net Asset Value
18th Dec 202512:35 pmRNSTransaction in Own Shares
18th Dec 202512:35 pmRNSTransaction in Own Shares
12th Dec 20251:53 pmRNSUnaudited Net Asset Value
10th Dec 20254:00 pmRNSTransaction in Own Shares
5th Dec 20253:44 pmRNSUnaudited Net Asset Value
2nd Dec 20252:24 pmRNSUnaudited Net Asset Value
1st Dec 20253:54 pmRNSTransaction in Own Shares
1st Dec 20259:43 amRNSTotal Voting Rights
28th Nov 20254:31 pmRNSTransaction in Own Shares
21st Nov 20254:42 pmRNSTransaction in Own Shares
21st Nov 20254:32 pmRNSUnaudited Net Asset Value
18th Nov 20251:06 pmRNSReplacement Net Asset Value(s) and Factsheet
17th Nov 20254:40 pmRNSNet Asset Value(s) and Factsheet
17th Nov 20259:17 amRNSTransaction in Own Shares
10th Nov 202511:20 amRNSNet Asset Value(s)
4th Nov 202512:33 pmRNSNet Asset Value(s)
3rd Nov 202510:05 amRNSTotal Voting Rights
30th Oct 202510:33 amRNSTransaction in Own Shares
24th Oct 20252:45 pmRNSNet Asset Value(s)
22nd Oct 20253:57 pmRNSTransaction in Own Shares
20th Oct 20251:39 pmRNSNet Asset Value(s)
10th Oct 20254:26 pmRNSNet Asset Value(s)
9th Oct 20257:01 amRNSDividend Declaration
9th Oct 20257:00 amRNSHalf-year Report
1st Oct 20255:00 pmRNSNet Asset Value(s)
26th Sep 20252:02 pmRNSNet Asset Value(s)
22nd Sep 202510:54 amRNSNet Asset Value(s)
12th Sep 20254:27 pmRNSNet Asset Value(s)
9th Sep 202511:43 amRNSCompliance with Market Abuse Regulation
8th Sep 20251:12 pmRNSNet Asset Value(s)
2nd Sep 202510:56 amRNSNet Asset Value(s)
26th Aug 20252:13 pmRNSNet Asset Value(s)
19th Aug 20252:36 pmRNSDirector/PDMR Shareholding
15th Aug 20254:11 pmRNSNet Asset Value(s)
13th Aug 20255:57 pmRNSResults of Requisitioned General Meeting
13th Aug 202511:48 amRNSResults of Requisitioned General Meeting
11th Aug 202512:09 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.